US$ 27.53
what is glp 1 agonist drugs Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]
Description
If weight loss is a treatment goal , GLP-1 medications are a more appropriate choice
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
Wei L, Mo W, Lan S, et al
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://canada1.discourse-cdn.com/flex033/uploads/medbound/optimized/2X/0/0f90790e05ec89faa7cfe787a33eb893e4a44a82_2_690x460.jpeg)
Jump to: GLP-1s for type 2 diabetes | GLP-1s for weight loss | Side effects and safety | Take home message GLP-1 receptor agonists (GLP-1s) are a class of medications approved for individuals living with type 2 diabetes and obesity to help lower blood glucose levels (blood sugar) and support weight loss
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://figures.semanticscholar.org/d4633364bbf2cc67e74fd3a60dd5180b7e50f90a/5-Table1-1.png)
Specifically, GLP-1RAs downregulate activation of VCAM1, the intracellular adhesion molecule-1 (ICAM-1) and plasminogen activator inhibitor type 1 (PAI-1) in endothelial cells [57]
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://revolutionhealth.org/cdn/shop/articles/GLP-1_comparison_for_weight_loss.png?v=1769219496)
doi: 10.1161/CIRCRESAHA.114.301958
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/AD_4nXecYXk7BfwC6adHH808V596nosg2pYs4yDUs6TBM_JMmx7_pGkjqpOwyHWy2Rj2TdJt-SPUxEipYqiO5CftWX-CaAm_fXRTU6dpEuJkuUscaLenZ1xGLWDdf_XVsOIjaZt08BpA4A.png)
Preliminary results indicate that such drugs might not only be effective for obesity and diabetes but also for a number of other diseases including osteoarthritis, Parkinson's disease and a range of conditions caused by a buildup of fat in the liver, known as nonalcoholic steatohepatitis (NASH) (Brandt, Mller, DiMarchi)
![what is glp 1 agonist drugs Evolution of GLP1 Receptor Agonists for Diabetes Treatment glp-1_analogs [TUSOM | Pharmwiki]](https://www.jneurosci.org/content/jneuro/45/46/e1375252025/F1.large.jpg?download=true)